News
-
Dispensary Corner 30 Jan 17
Monday | Jan 30 2017American corn chip brand Tostitos has released a limited edition packaging which warns if you’ve had.
-
Weekly Comment 30 Jan 17: Get back on track with Milk Thistle – a powerful liver detoxifier
Monday | Jan 30 2017This week's contributor is Natasha McKay, SOUTHERNATURE Naturopath & Herbalist.
-
New NSW health minister
Monday | Jan 30 2017THE NSW branch of the Pharmacy Guild of Australia has welcomed the appointment of Brad Hazzard as the state's new health minister, with the appointment announced following the resignation of long-time incumbent Jillian Skinner.
-
CW marks CNY
Monday | Jan 30 2017CHEMIST Warehouse yesterday marked its support for Melbourne's Chinese New Year 2017 Festival, kicking off daily Tai Chi classes at Queensbridge Square on the Yarra's Southbank.
-
Ezetimibe consult
Monday | Jan 30 2017THE Health Department has opened public consultation on the draft report to the Pharmaceutical Benefits Advisory Committee on the Post-market Review of ezetimibe.
-
Extended hours call
Monday | Jan 30 2017CEO of Bendigo Health in Victoria, John Mulder, has urged extended hours for retail pharmacies as a means of helping take the pressure off hospital emergency departments.
-
Two consultations
Monday | Jan 30 2017THE Senate Standing Committee on Community Affairs has two open consultations relevant to pharmacists.
-
US pharmacists for underserved areas
Monday | Jan 30 2017THE US National Community Pharmacists Association (NCPA) has endorsed the Pharmacy and Medically Underserved Areas Enhancement Act, legislation recognising pharmacists as health care providers, enabling them in medically underserved areas to offer and be compensated for an expanded scope of patient-care services.
-
Availability updates
Monday | Jan 30 2017GLAXOSMITHKLINE Australia has advised the Therapeutic Goods Administration (TGA) that its impetigo treatment Bactroban 20mg/g which has been in short supply (PD 01 Jun 16) will become available from Feb this year.
-
FDA warns on Hylands
Monday | Jan 30 2017THE US Food and Drug Administration (FDA) has heightened its warning level about homeopathic teething products (PD 04 Oct), formally advising that tablets containing belladonna pose an unnecessary risk to infants.
